Previous close | 0.0080 |
Open | 0.0060 |
Bid | 0.0080 x N/A |
Ask | 0.0160 x N/A |
Day's range | 0.0060 - 0.0080 |
52-week range | 0.0025 - 0.0325 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VANCOUVER, British Columbia, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Q Battery Metals (CSE:QMET) (OTCPink:BTKRF) (FSE:0NB), a mineral exploration company focused on exploration and development of battery, base, and precious metals, has closed the acquisition of its Pontax Lithium Project within the Quebec’s “Lithium Triangle”. The company’s newly acquired property, strategically positioned in an exceptionally active and promising area for lithium exploration, is an exploration stage project that has p
SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced a clinical supply agreement with AstraZeneca in China to evaluate the safety and efficacy of BBP-398, an investigational SHP2 inhibitor, in combination with AstraZeneca’s osimertinib, an epidermal growth factor receptor (EGFR) inhibitor, in a Phase 1 clinical study for